Political Ecology

Environmental legislation is commonly accepted as an altruistic approach to land management. A closer examination however, reveals that political incentives and flawed arguments consistently shape U.S. environmental policy at high public costs. As student fellows at the Institute of Political Economy at Utah State University, we have had the opportunity to research this subject under the direction of Professor Randy Simmons. Political Ecology is his upcoming book that explores a variety of environmental policies, the incentives that created them, and their effects on both public lands and taxpayers. Our research contributions to this overall project specifically explore three separate case studies: the Federal Land Management Policy Act, the Clean Air Act, and the Energy Policy Act of 2005. Altogether, it is our hope that the analysis and case studies presented will provide policy makers and the general public with needed information in regards to current and future U.S. environmental policy

Regional data exchange to improve care for veterans after non-VA hospitalization: a randomized controlled trial

BACKGROUND: Coordination of care, especially after a patient experiences an acute care event, is a challenge for many health systems. Event notification is a form of health information exchange (HIE) which has the potential to support care coordination by alerting primary care providers when a patient experiences an acute care event. While promising, there exists little evidence on the impact of event notification in support of reengagement into primary care. The objectives of this study are to 1) examine the effectiveness of event notification on health outcomes for older adults who experience acute care events, and 2) compare approaches to how providers respond to event notifications. METHODS: In a cluster randomized trial conducted across two medical centers within the U.S. Veterans Health Administration (VHA) system, we plan to enroll older patients (≥ 65 years of age) who utilize both VHA and non-VHA providers. Patients will be enrolled into one of three arms: 1) usual care; 2) event notifications only; or 3) event notifications plus a care transitions intervention. In the event notification arms, following a non-VHA acute care encounter, an HIE-based intervention will send an event notification to VHA providers. Patients in the event notification plus care transitions arm will also receive 30 days of care transition support from a social worker. The primary outcome measure is 90-day readmission rate. Secondary outcomes will be high risk medication discrepancies as well as care transitions processes within the VHA health system. Qualitative assessments of the intervention will inform VHA system-wide implementation. DISCUSSION: While HIE has been evaluated in other contexts, little evidence exists on HIE-enabled event notification interventions. Furthermore, this trial offers the opportunity to examine the use of event notifications that trigger a care transitions intervention to further support coordination of care. TRIAL REGISTRATION: ClinicalTrials.gov NCT02689076. "Regional Data Exchange to Improve Care for Veterans After Non-VA Hospitalization." Registered 23 February 2016

The Vehicle, Spring 2010

Table of Contents ForgettingRashelle McNairpage 34 MuseMary Lieskepage 35 My CompulsionAshton Tembypage 38 MemoryKate Vandermeerpage 41 Killmercialize MeGreg Petersonpage 42 PenJake Smithpage 46 GrassKate Vandermeerpage 48 Character CreationMary Lieskepage 52 Ring Around TheKim Hunter-Perkinspage 54 The Great Cursive ScareJake Smithpage 55 OpiateDoug Urbanskipage 61 What Happens to Little Girls...Jennifer O\u27Neilpage 63 Poetry Sunny DaysRyan Poolpage 2 AtlantisDoug Urbanskipage 4 Garbage CityKate Vandermeerpage 6 Fat Girl ThongsKim Hunter-Perkinspage 7 MercilessRosalia Pecorapage 19 ChemistryMary Lieskepage 20 He-Who-Stopped-TalkingJustin Sudkamppage 22 In Which Iris Contemplates a Barren EarthSean Slatterypage 24 At the Bottom of the WorldNick Canadaypage 27 Dogma: Mush!Scott Maypage 28 ThiefMary Lieskepage 29 Prose Coming HomeDoug Urbanskipage 8 DodoDan Davispage 31 The Poet in the PedestrianScott Maypage 37 Toxic RainJacob Swansonpage 40 What\u27s Your Greatest Fear?Justine Fittonpage 43 Soul VoiceHolly Thomaspage 49 Conversations with a SniperKim Hunter-Perkinspage 56 LettersDaniel Paquinpage 65 Art San Marcos, MexicoKate Vandermeercover Contemplation of the World\u27s EndNicholas Giffordpage 18 Little Lady SitsSarah Hadwigerpage 26 MoodAlycia Rockeypage 30 Four Ducks in a RowMegan Mathypage 36 The Daily EasternBen Tillerypage 39 BirdsAlycia Rockeypage 45 March of the BugsMegan Mathypage 47 Mexico Work ExperienceKate Vandermeerpage 53 Feather and JewelsAlycia Rockeypage 60 The ForgottenMegan Mathypage 64 Special Features Fall 2009-Spring 2010 Vehicle Award Winnerspage 1 James K. Johnson Creative Writing Awardpage 74 Kim Hunter-PerkinsWinning Entries (Poetry)page 75 Clint WalkerWinning Entry (Fiction)page 86 Faculty Spotlight: Professor Jason Brownpage 99 About the Contributorspage 106 About the Editorspage 110https://thekeep.eiu.edu/vehicle/1093/thumbnail.jp

Assessment of second-line antiretroviral regimens for HIV therapy in Africa.

BACKGROUND: The efficacy and toxic effects of nucleoside reverse-transcriptase inhibitors (NRTIs) are uncertain when these agents are used with a protease inhibitor in second-line therapy for human immunodeficiency virus (HIV) infection in resource-limited settings. Removing the NRTIs or replacing them with raltegravir may provide a benefit. METHODS: In this open-label trial in sub-Saharan Africa, we randomly assigned 1277 adults and adolescents with HIV infection and first-line treatment failure to receive a ritonavir-boosted protease inhibitor (lopinavir-ritonavir) plus clinician-selected NRTIs (NRTI group, 426 patients), a protease inhibitor plus raltegravir in a superiority comparison (raltegravir group, 433 patients), or protease-inhibitor monotherapy after 12 weeks of induction therapy with raltegravir in a noninferiority comparison (monotherapy group, 418 patients). The primary composite end point, good HIV disease control, was defined as survival with no new World Health Organization stage 4 events, a CD4+ count of more than 250 cells per cubic millimeter, and a viral load of less than 10,000 copies per milliliter or 10,000 copies or more with no protease resistance mutations at week 96 and was analyzed with the use of imputation of data (≤4%). RESULTS: Good HIV disease control was achieved in 60% of the patients (mean, 255 patients) in the NRTI group, 64% of the patients (mean, 277) in the raltegravir group (P=0.21 for the comparison with the NRTI group; superiority of raltegravir not shown), and 55% of the patients (mean, 232) in the monotherapy group (noninferiority of monotherapy not shown, based on a 10-percentage-point margin). There was no significant difference in rates of grade 3 or 4 adverse events among the three groups (P=0.82). The viral load was less than 400 copies per milliliter in 86% of patients in the NRTI group, 86% in the raltegravir group (P=0.97), and 61% in the monotherapy group (P<0.001). CONCLUSIONS: When given with a protease inhibitor in second-line therapy, NRTIs retained substantial virologic activity without evidence of increased toxicity, and there was no advantage to replacing them with raltegravir. Virologic control was inferior with protease-inhibitor monotherapy. (Funded by European and Developing Countries Clinical Trials Partnership and others; EARNEST Current Controlled Trials number, ISRCTN37737787, and ClinicalTrials.gov number, NCT00988039.)

Student Recital (December 8, 2015)

Four Rotations for Solo Marimba / Eric Sammut I. Spencer Lusignan, marimba Trombone Concerto / Nicolai Rimsky-Korsakov Allegro vivace Andante cantabile Sarah Emanuel, trombone When I think upon the maidens / Michael Head O del mio dolce ardor / Christoph Willibald Gluck Robert Gariepy, bass Sonatina to David Russell / Jorge Morel Allegretto Nicholas Moreira, guitar Goodnight Moon / Eric Whitacre Taylor Eckstrom, soprano Sonate I for Flute / Paul Hindemith Heiter bewegt Ian Maguire, flute Etude No. 4 des Accords répétés, W 235 / Heitor Villa-Lobos Sean Donovan, guitar Sonata I / Johann Ernst Galliard Cantabile Spiritoso e staccato Largo e staccato Hornpipe a l’Inglese Vivace Cody O’Toole, trombone Berta’s Aria (The Barber of Seville) / Gioachino Rossini Justine Smigel, soprano When I have sung my songs / Ernest Charles Emily Mills, soprano Romanze, Opus 13, No. 1 / Johann Kaspar Mertz Lieblied, Opus 13, No. 4 Nolan Driscoll, guitar Hommage a Villa-Lobos / Roland Dyens Andantinostalgie Prelude No. 5, W 419 / Heitor Villa-Lobos Austin DeAndrade, guitar Gretchen am Spinnrade, D. 118 / Franz Schubert Volta la terra (Un Ballo in Maschera) / Giuseppe Verdi Angela Maloney, sopranohttps://vc.bridgew.edu/student_concerts/1102/thumbnail.jp

Student Recital (December 7, 2015)

Choro de Saudade / Agustin Barrios Mangore Nolan Driscoll, guitar My mother bids me bind my hair / Franz Josef Haydn Willow Song (The Ballad of Baby Doe) / Douglas Moore Elizabeth Lach, soprano Thoughts of Love / Arthur Pryor I. Tempo di valse II. Tempo di valse III. Tempo di valse Nicholas Grisolia, euphonium Che gelida manina (La Boheme) / Giacomo Puccini Richard Moran, tenor Sonata 5 in F Major, Opus 24 / Ludwig van Beethoven Allegro Megan Polk, violin O vos omnes (The Seven Last Words of Christ) / Theodore Dubois Colleen McDonough, soprano Hommage a Villa-Lobos / Roland Dyens Andantinostalgie Tuhu Austin DeAndrade, guitar Morgen, Opus 21, No. 4 / Richard Strauss Justine Smigel, soprano Nature beyond art / Thomas Arne Xavier Cosme, tenor Violin Concerto No. 3 in G Major, K. 216 / W. A. Mozart Allegro Gail Colombo, violin Yu Guang Qu (Song of the Fisherman) / Guang Ran Jiaying Zhu, soprano El Decameron Negro / Leo Brouwer El arpa del guerrero Killian Kerrigan, guitar Una donna quindici anni (Cosi fan tutte), K. 588 / Wolfgang Amadeus Mozart Angela Maloney, soprano Concert Etude, Opus 49 / Alexander Goedicke Lindsey Cook, trumpethttps://vc.bridgew.edu/student_concerts/1101/thumbnail.jp

Health system performance for people with diabetes in 28 low- and middle-income countries:A cross-sectional study of nationally representative surveys

International audienceThe prevalence of diabetes is increasing rapidly in low- and middle-income countries (LMICs), urgently requiring detailed evidence to guide the response of health systems to this epidemic. In an effort to understand at what step in the diabetes care continuum individuals are lost to care, and how this varies between countries and population groups, this study examined health system performance for diabetes among adults in 28 LMICs using a cascade of care approach

Electrophysiology of Inhibitory Control in the Context of Emotion Processing in Children With Autism Spectrum Disorder

Autism Spectrum Disorder (ASD) is an increasingly common developmental disorder that affects 1 in 59 children. Despite this high prevalence of ASD, knowledge regarding the biological basis of its associated cognitive difficulties remains scant. In this study, we aimed to identify altered neurophysiological responses underlying inhibitory control and emotion processing difficulties in ASD, together with their associations with age and various domains of cognitive and social function. This was accomplished by assessing electroencephalographic recordings during an emotional go/nogo task alongside parent rating scales of behavior. Event related potential (ERP) N200 component amplitudes were reduced in children with ASD compared to typically developing (TD) children. No group differences were found, however, for task performance, P300 amplitude or latency, or N170 amplitude or latency, suggesting that individuals with ASD may only present conflict monitoring abnormalities, as reflected by the reduced N200 component, compared to TD individuals. Consistent with previous findings, increased age correlated with improved task performance scores and reduced N200 amplitude in the TD group, indicating that as these children develop, their neural systems become more efficient. These associations were not identified in the ASD group. Results also showed significant associations between increased N200 amplitudes and improved executive control abilities and decreased autism traits in TD children only. The newly discovered findings of decreased brain activation in children with ASD, alongside differences in correlations with age compared to TD children, provide a potential neurophysiological indicator of atypical development of inhibitory control mechanisms in these individuals

Urological cancer care pathways: development and use in the context of systematic reviews and clinical practice guidelines

Background: Making healthcare treatment decisions is a complex process involving a broad stakeholder base including patients, their families, health professionals, clinical practice guideline developers and funders of healthcare. Methods: This paper presents a review of a methodology for the development of urological cancer care pathways (UCAN care pathways), which reflects an appreciation of this broad stakeholder base. The methods section includes an overview of the steps in the development of the UCAN care pathways and engagement with clinical content experts and patient groups. Results: The development process is outlined, the uses of the urological cancer care pathways discussed and the implications for clinical practice highlighted. The full set of UCAN care pathways is published in this paper. These include care pathways on localised prostate cancer, locally advanced prostate cancer, metastatic prostate cancer, hormone-resistant prostate cancer, localised renal cell cancer, advanced renal cell cancer, testicular cancer, penile cancer, muscle invasive and metastatic bladder cancer and non-muscle invasive bladder cancer. Conclusion: The process provides a useful framework for improving urological cancer care through evidence synthesis, research prioritisation, stakeholder involvement and international collaboration. Although the focus of this work is urological cancers, the methodology can be applied to all aspects of urology and is transferable to other clinical specialties.11 page(s